A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...

The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...

(Yicai) Jan. 3 -- US pharmaceutical company Gilead Sciences has been given the greenlight by Chinese regulators to sell its ...

Lenacapavir (previously GS-6207) is the first in a new class of class HIV-1 capsid inhibitor that Gilead is hoping will eventually free patients from the need to take daily oral tablets ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly ... with Gilead's already-marketed capsid inhibitor Sunlenca (lenacapavir ...

Dec. 11, 2024 — Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that may help to ...

The future may be getting brighter in terms of reducing the threat of the human immunodeficiency virus (HIV), infectious disease experts told Newsweek. With new treatments and maybe even a vaccine ...

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...

编者按：2025年1月2日，国家药品监督管理局（NMPA）官网显示[1]，吉利德（上海）医药科技有限公司的Lenacapavir（LEN，来那帕韦钠片和来那帕韦钠注射液）正式获批，用于与其他抗反转录病毒（ARV）药物联合使用,治疗当前方案无法达到病毒 ...

The trucks in the New Orleans attack and Las Vegas explosion were rented on Turo. Here's what to know about the app. Rates ...